eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | metabolic syndrome x |
| Symptom | C0027051|myocardial infarction |
| Sentences | 17 |
| PubMedID- 23411742 | Aim of this study was to determine the prevalence of metabolic syndrome in patients with premature myocardial infarction (before 50 years of age). |
| PubMedID- 22263382 | metabolic syndrome and outcome in patients with acute myocardial infarction. |
| PubMedID- 20811489 | We sought to determine and compare the prevalence of the metabolic syndrome (ms) in patients with acute myocardial infarction (ami) utilizing the new international diabetes federation (idf) definition with the older national cholesterol education program (ncep) definition. |
| PubMedID- 23715346 | Considering inclusion and exclusion criteria total 100 patients were included and divided into two groups, group a - acute myocardial infarction (ami) with metabolic syndrome (ms) and group b - acute myocardial infarction (ami) without metabolic syndrome (ms). |
| PubMedID- 25789257 | This finding might partly explain the higher risk of development of heart failure following acute myocardial infarction in patients with metabolic syndrome. |
| PubMedID- 23934969 | Objective: this study aimed to evaluate long-term survival according to the presence of metabolic syndrome (ms) in patients with acute myocardial infarction (ami) undergoing successful percutaneous coronary intervention (pci) with drug-eluting stents (des). |
| PubMedID- 22701134 | The aim of this study was to evaluate clinical impact of non-hdl-c and apob on clinical outcomes in metabolic syndrome (ms) patients with acute myocardial infarction (ami) undergoing percuatneous coronary intervetion. |
| PubMedID- 21428179 | Conclusion: elevated homocysteine levels were correlated to the metabolic syndrome in patients with prior myocardial infarction. |
| PubMedID- 24020829 | Intra-thoracic fat volume is associated with myocardial infarction in patients with metabolic syndrome. |
| PubMedID- 19356813 | Obesity and the metabolic syndrome in patients with acute myocardial infarction. |
| PubMedID- 21757819 | Background: the purpose of the present study was to compare the efficacy and safety of paclitaxel-eluting stent (pes), sirolimus-eluting stent (ses), and zotarolimus-eluting stent (zes) in primary percutaneous coronary intervention (pci) for acute st-segment elevation myocardial infarction (stemi) with metabolic syndrome (ms). |
| PubMedID- 20890426 | We sought to determine the prevalence of metabolic syndrome (ms) in patients with acute myocardial infarction and its effect on clinical outcomes. |
| PubMedID- 25563711 | Conclusions: this prospective observational cohort trial demonstrated that chronic ace-i therapy was an independent predictor for reduced periprocedural myocardial infarction among patients with metabolic syndrome who underwent elective coronary intervention. |
| PubMedID- 22240598 | Coronary artery bypass grafting for multivessel coronary artery disease in metabolic syndrome patients with acute myocardial infarction. |
| PubMedID- 22971940 | Presence of metabolic syndrome is associated with larger myocardial infarction size and complications following acute myocardial infarction. |
| PubMedID- 20509277 | Aim: to analyze the components of metabolic syndrome from patients with cardiovascular disease (myocardial infarction). |
| PubMedID- 21129152 | It also reduced the risk of myocardial infarction in patients with severe metabolic syndrome by 56% (8 year follow-up) and the development of type 2 diabetes by almost half (2 and 5 year follow-up) . |
Page: 1